Back to Search
Start Over
Antimicrobial effects of epigallocatechin-3-gallate, a catechin abundant in green tea, on periodontal disease-associated bacteria.
- Source :
-
Archives of oral biology [Arch Oral Biol] 2024 Nov; Vol. 167, pp. 106063. Date of Electronic Publication: 2024 Jul 31. - Publication Year :
- 2024
-
Abstract
- Objective: Epigallocatechin-3-gallate (EGCG), a catechin abundant in green tea, exhibits antibacterial activity. In this study, the antimicrobial effects of EGCG on periodontal disease-associated bacteria (Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens, Fusobacterium nucleatum, and Fusobacterium periodontium) were evaluated and compared with its effects on Streptococcus mutans, a caries-associated bacterium.<br />Results: Treatment with 2 mg/ml EGCG for 4 h killed all periodontal disease-associated bacteria, whereas it only reduced the viable count of S. mutans by about 40 %. Regarding growth, the periodontal disease-associated bacteria were more susceptible to EGCG than S. mutans, based on the growth inhibition ring test. As for metabolism, the 50 % inhibitory concentration (IC <subscript>50</subscript> ) of EGCG for bacterial metabolic activity was lower for periodontal disease-associated bacteria (0.32-0.65 mg/ml) than for S. mutans (1.14 mg/ml). Furthermore, these IC <subscript>50</subscript> values were negatively correlated with the growth inhibition ring (r = -0.73 to -0.86). EGCG induced bacterial aggregation at the following concentrations: P. gingivalis (>0.125 mg/ml), F. periodonticum (>0.5 mg/ml), F. nucleatum (>1 mg/ml), and P. nigrescens (>2 mg/ml). S. mutans aggregated at an EGCG concentration of > 1 mg/ml.<br />Conclusion: EGCG may help to prevent periodontal disease by killing bacteria, inhibiting bacterial growth by suppressing bacterial metabolic activity, and removing bacteria through aggregation.<br />Competing Interests: Declaration of Competing Interest The authors declare that there are no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.<br /> (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Subjects :
- Fusobacterium drug effects
Microbial Sensitivity Tests
Anti-Bacterial Agents pharmacology
Prevotella nigrescens drug effects
Humans
Catechin pharmacology
Catechin analogs & derivatives
Tea chemistry
Streptococcus mutans drug effects
Periodontal Diseases microbiology
Periodontal Diseases drug therapy
Porphyromonas gingivalis drug effects
Fusobacterium nucleatum drug effects
Prevotella intermedia drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1879-1506
- Volume :
- 167
- Database :
- MEDLINE
- Journal :
- Archives of oral biology
- Publication Type :
- Academic Journal
- Accession number :
- 39128436
- Full Text :
- https://doi.org/10.1016/j.archoralbio.2024.106063